Nuvation Bio (NUVB-WT) Receivables - Other (2023 - 2025)
Nuvation Bio (NUVB-WT) has disclosed Receivables - Other for 3 consecutive years, with $3.3 million as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 7.98% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, down 7.98% year-over-year, with the annual reading at $3.3 million for FY2025, 7.98% down from the prior year.
- Receivables - Other for Q4 2025 was $3.3 million at Nuvation Bio, down from $5.5 million in the prior quarter.
- The five-year high for Receivables - Other was $5.5 million in Q3 2025, with the low at $2.3 million in Q1 2023.
- Average Receivables - Other over 3 years is $3.8 million, with a median of $3.8 million recorded in 2023.
- The sharpest move saw Receivables - Other soared 88.43% in 2024, then decreased 7.98% in 2025.
- Over 3 years, Receivables - Other stood at $3.7 million in 2023, then dropped by 3.57% to $3.6 million in 2024, then decreased by 7.98% to $3.3 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $3.3 million, $5.5 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.